Shivalik Rasayan Latest Share Price (SHIVALIK)
TODAY IN ONE LINE
With a market cap of ₹442.82 Cr., it trades at a P/E of 29.16. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Shivalik Rasayan flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.19x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Price MomentumStock underperformed, dropping 14.6% over 1Y
- ●Earnings DeclineEPS (TTM) has contracted by 3.2% YoY
- ●Poor Capital ReturnsLow ROE of 3.0%
Latest Shivalik Rasayan News
What changed recently?
Recent events, corporate actions, and announcements.
Shivalik Rasayan Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Shivalik Rasayan Limited, framed against the sector median so the premium or discount is obvious at a glance.
Shivalik Rasayan Limited trades at a P/E of 29.16× and P/B of 0.67×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Shivalik Rasayan Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Shivalik Rasayan Limited — derived from the latest tape, not yesterday's close.
Shivalik Rasayan Limited last traded at ₹252.5 with an intraday range of ₹250.1–₹275.7 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹252.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 319.97 | +67.47 | +26.72% |
| R3 | 294.37 | +41.87 | +16.58% |
| R2 | 285.03 | +32.53 | +12.88% |
| R1 | 268.77 | +16.27 | +6.44% |
| PIVOT | 259.43 | 6.93 | 2.75% |
| CURRENT | 252.50 | — | — |
| S1 | 243.17 | -9.33 | -3.70% |
| S2 | 233.83 | -18.67 | -7.39% |
| S3 | 217.57 | -34.93 | -13.83% |
| S4 | 191.97 | -60.53 | -23.97% |
SHIVALIK is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Below opening range, showing Bearishness
Shivalik Rasayan Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Shivalik Rasayan Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Shivalik Rasayan Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹442.82 Cr. and reported EPS of ₹8.88.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 312 | 368 ▲ 18.0% |
| Sales Growth YoY %Derived | 14.21% | 18.04% |
| Other Income | 8 | 4 ▼ 50.9% |
| Total Income | 320 | 372 ▲ 16.2% |
| 160 | 188 ▲ 17.4% | |
| Gross ProfitDerived | 151 | 180 ▲ 18.7% |
| Gross Margin %Derived | 48.55% | 48.81% |
| 111 | 134 ▲ 20.4% | |
| EBITDA (Operating Profit)Derived | 40 | 46 ▲ 13.8% |
| OPM %Derived | 12.90% | 12.44% |
| 25 | 28 ▲ 13.0% | |
| Profit Before Tax (PBT) | 23 | 21 ▼ 8.3% |
| 3 | 4 ▲ 17.5% | |
| Effective Tax %Derived | 12.75% | 16.33% |
| Total Profit for Period | 20 | 18 ▼ 12.0% |
| Less: Non-controlling Interests | 4 | 6 ▲ 56.5% |
| Net Profit (Owner's PAT)Derived | 17 | 12 ▼ 27.3% |
| Net Profit Margin %Derived | 5.36% | 3.30% |
| PAT Growth YoY %Derived | 2.05% | -27.31% |
| Earnings Per Share (EPS ₹) | 10.60 | 7.71 ▼ 27.3% |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 297 | 351 ▲ 18.2% |
| Material Cost % of RevenueDerived | 55.63% | 53.53% |
| Employee Cost % of RevenueDerived | 17.65% | 16.45% |
| Other Cost % of RevenueDerived | 18.01% | 19.92% |
| Interest Coverage (x)Derived | 2.62x | 2.81x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 171 | 186 ▲ 9.2% | 198 ▲ 6.1% | 215 ▲ 8.7% | 234 ▲ 9.2% | 273 ▲ 16.4% | 312 ▲ 14.2% | 368 ▲ 18.0% | |
| Sales Growth YoY %Derived | — | 9.22% | 6.07% | 8.69% | 9.17% | 16.44% | 14.21% | 18.04% | |
| Other Income | 8 | 3 ▼ 60.7% | 1 ▼ 64.0% | 4 ▲ 227.7% | 5 ▲ 25.7% | 4 ▼ 14.7% | 8 ▲ 108.9% | 4 ▼ 50.9% | |
| Total Income | 179 | 189 ▲ 6.1% | 199 ▲ 4.9% | 218 ▲ 9.9% | 239 ▲ 9.5% | 277 ▲ 15.8% | 320 ▲ 15.6% | 372 ▲ 16.2% | |
111 | 114 ▲ 2.2% | 107 ▼ 5.9% | 94 ▼ 11.9% | 115 ▲ 21.9% | 140 ▲ 21.9% | 160 ▲ 14.7% | 188 ▲ 17.4% | ||
| Gross ProfitDerived | 59 | 73 ▲ 22.3% | 91 ▲ 24.8% | 121 ▲ 33.0% | 120 ▼ 0.8% | 133 ▲ 11.2% | 151 ▲ 13.7% | 180 ▲ 18.7% | |
| Gross Margin %Derived | 34.82% | 39.00% | 45.90% | 56.17% | 51.07% | 48.77% | 48.55% | 48.81% | |
36 | 44 ▲ 22.1% | 53 ▲ 19.6% | 74 ▲ 40.1% | 77 ▲ 3.9% | 94 ▲ 22.4% | 111 ▲ 18.3% | 134 ▲ 20.4% | ||
| EBITDA (Operating Profit)Derived | 23 | 29 ▲ 22.6% | 38 ▲ 32.9% | 47 ▲ 23.2% | 43 ▼ 8.1% | 39 ▼ 8.8% | 40 ▲ 2.6% | 46 ▲ 13.8% | |
| OPM %Derived | 13.65% | 15.32% | 19.21% | 21.77% | 18.32% | 14.35% | 12.90% | 12.44% | |
5 | 5 ▼ 1.7% | 10 ▲ 103.3% | 14 ▲ 33.0% | 16 ▲ 18.1% | 20 ▲ 25.4% | 25 ▲ 25.5% | 28 ▲ 13.0% | ||
| Profit Before Tax (PBT) | 26 | 27 ▲ 1.9% | 29 ▲ 8.4% | 37 ▲ 27.8% | 32 ▼ 14.3% | 23 ▼ 26.9% | 23 ▲ 1.1% | 21 ▼ 8.3% | |
5 | 5 ▼ 11.3% | 4 ▼ 11.3% | 3 ▼ 34.4% | 2 ▼ 32.4% | 5 ▲ 177.8% | 3 ▼ 41.3% | 4 ▲ 17.5% | ||
| Effective Tax %Derived | 20.01% | 17.42% | 14.25% | 7.32% | 5.78% | 21.95% | 12.75% | 16.33% | |
| Total Profit for Period | 21 | 22 ▲ 5.2% | 25 ▲ 12.5% | 34 ▲ 38.1% | 30 ▼ 12.9% | 18 ▼ 39.4% | 20 ▲ 13.0% | 18 ▼ 12.0% | |
| Less: Non-controlling Interests | — | — | — | — | — | 2 | 4 ▲ 117.8% | 6 ▲ 56.5% | |
| Net Profit (Owner's PAT)Derived | 21 | 22 ▲ 5.2% | 25 ▲ 12.5% | 34 ▲ 38.1% | 30 ▼ 12.9% | 16 ▼ 45.2% | 17 ▲ 2.1% | 12 ▼ 27.3% | |
| Net Profit Margin %Derived | 12.28% | 11.83% | 12.55% | 15.95% | 12.72% | 5.99% | 5.36% | 3.30% | |
| PAT Growth YoY %Derived | — | 5.24% | 12.52% | 38.09% | -12.90% | -45.16% | 2.05% | -27.31% | |
| Earnings Per Share (EPS ₹) | 15.20 | 16.00 ▲ 5.3% | 18.00 ▲ 12.5% | 23.64 ▲ 31.3% | 20.59 ▼ 12.9% | 10.51 ▼ 49.0% | 10.60 ▲ 0.9% | 7.71 ▼ 27.3% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 5.2% | 1 ▲ 0.0% | 2 ▲ 7.4% | 2 ▲ 1.2% | 2 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 152 | 163 ▲ 6.8% | 170 ▲ 4.3% | 182 ▲ 6.9% | 207 ▲ 14.3% | 254 ▲ 22.3% | 297 ▲ 16.9% | 351 ▲ 18.2% | |
| Material Cost % of RevenueDerived | 63.60% | 62.10% | 53.42% | 47.46% | 56.58% | 57.17% | 55.63% | 53.53% | |
| Employee Cost % of RevenueDerived | 7.70% | 8.77% | 10.72% | 13.89% | 15.75% | 17.15% | 17.65% | 16.45% | |
| Other Cost % of RevenueDerived | 13.46% | 14.91% | 15.97% | 20.52% | 17.00% | 17.27% | 18.01% | 19.92% | |
| Interest Coverage (x)Derived | 9.86x | 16.86x | 18.65x | 14.32x | 7.22x | 3.51x | 2.62x | 2.81x |
Shivalik Rasayan segment analysis : revenue and profit mix.
Disclosed business segments at Shivalik Rasayan with their share of revenue and profit, switchable between consolidated and standalone reporting.
Shivalik Rasayan discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Shivalik Rasayan Limited.
Our AI distills the core fundamental drivers supporting Shivalik Rasayan Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Shivalik Rasayan Limited's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Debt-to-equity ratio is very low at 0.18, indicating strong financial health.
Consistent revenue growth. 5-year CAGR of 10.85% and 3-year CAGR of 13.23%.
Robust quarterly sales growth of 19.70% demonstrates strong recent market demand.
Diversified product portfolio across Agrochemicals and Pharmaceutical APIs mitigates risks.
Increasing FII confidence, with holdings rising from 0.04% to 4.38% recently.
Key Risks.
Low profitability ratios. ROE 1.56% and ROCE 5.51% indicate inefficient capital use.
Sharp quarterly profit decline of -54.60% raises concerns about recent performance.
High P/E ratio of 43.76 appears overvalued compared to sector P/E 42.07.
Negative EPS growth over 3 years (-16.36%) and low 5-year growth (0.84%).
Negative annual cash flow per share (-20.46) indicates poor operational cash generation.
Flip Conditions.
Valuation risk. a P/E above 38 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Shivalik Rasayan Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Shivalik Rasayan Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Shivalik Rasayan Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Shivalik Rasayan Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Shivalik Rasayan Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Shivalik Rasayan Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Shivalik Rasayan Limited stood at 62.3% of traded volume, against a 20-day average of 53.8%.
Shivalik Rasayan announcements: results, concalls, ratings, M&A.
Filings Shivalik Rasayan sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Shivalik Rasayan files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 45 documents below.
Shareholders meeting
Revised Voting Results & Scrutinizer's Report for the Extra-Ordinary General Meeting held on 20.08.2026
Shareholders meeting
Shivalik Rasayan Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on August 20, 2026. Further, the…
Shareholders meeting
Shivalik Rasayan Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on August 20, 2026
Copy of Newspaper Publication
Shivalik Rasayan Limited has informed the Exchange about Copy of Newspaper Publication
General Updates
Shivalik Rasayan Limited has informed the Exchange about submission of BRSR report
Shivalik Rasayan dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Shivalik Rasayan has declared, sequenced by announce and record date.
Shivalik Rasayan corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Shivalik Rasayan Limited: business, sector, key facts.
What Shivalik Rasayan Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Shivalik Rasayan Limited operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: SHIVALIK, BSE: 539148.
Shivalik Rasayan Limited (SRL) is an Indian chemical manufacturing company primarily focused on the production and sale of agrochemicals and pharmaceutical ingredients. A significant portion of their business involves the creation of plant protection chemicals for the agricultural sector. This includes the manufacture of key active ingredients such as Dimethoate technical and Malathion technical. Dimethoate technical serves as a base for creating formulations used to control insects and mites affecting various crops, while Malathion technical, an organophosphate insecticide, finds application in controlling pests on numerous food and feed crops. Their expertise extends to the broader manufacturing of organophosphorus-based insecticides and other related chemicals.
Beyond agrochemicals, SRL also plays a substantial role in the pharmaceutical industry. They are involved in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs). These APIs cater to a diverse range of therapeutic areas, including oncology (cancer treatment), antiretroviral drugs (ARVs) used to combat HIV/AIDS, cardiovascular medications, treatments for metabolic disorders, and immunology-related drugs. This diversification into pharmaceutical APIs significantly broadens SRL’s product portfolio and market reach.
In addition to their own product lines, SRL offers custom chemical manufacturing services. This aspect of their business allows them to cater to the specific needs of other companies requiring specialized chemical synthesis or formulation. This contract manufacturing capability adds another revenue stream and demonstrates their flexibility and expertise in chemical processing. The company's established infrastructure and experience in chemical production likely make them a competitive choice for companies outsourcing their manufacturing needs.
Established in 1979 and headquartered in New Delhi, India, Shivalik Rasayan Limited has a long history in the chemical industry. Their integrated approach encompassing both agrochemicals and pharmaceutical APIs positions them uniquely in the Indian market. This strategy allows for potential synergies between their divisions, and diversification mitigates risks associated with relying heavily on any single market sector. The company's continued success will likely depend on its ability to innovate, adapt to evolving market demands, and maintain its competitive edge in both the agricultural and pharmaceutical sectors.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Astec LifeSciences (ASTEC) Share PricePeer
- Bhagiradha Chemicals & Industries (BHAGCHEM) Share PricePeer
- Bharat Rasayan (BHARATRAS) Share PricePeer
- Dhanuka Agritech (DHANUKA) Share PricePeer
- Dharmaj Crop Guard (DHARMAJ) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Shivalik Rasayan Limited (SHIVALIK).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Shivalik Rasayan Limited (SHIVALIK)?
The current share price of Shivalik Rasayan Limited (SHIVALIK) is ₹252.50. Today, the stock has declined by ₹18.80 (6.93%), trading in a range of ₹250.10 to ₹275.70. The stock opened at ₹275.70 with a trading volume of 1,11,906 shares.
02Is Shivalik Rasayan Limited stock a good investment for long-term?
Shivalik Rasayan Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹442.82 Cr., P/E ratio of 29.16, ROE of 3%, and ROCE of 5.51%. The dividend yield stands at 0.22%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Shivalik Rasayan Limited stock?
The 52-week high price of Shivalik Rasayan Limited (SHIVALIK) is ₹503.00, while the 52-week low is ₹206.75. Currently trading at ₹252.50, the stock is 22.13% above its 52-week low and 49.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Shivalik Rasayan Limited stock at the current price?
Whether to buy Shivalik Rasayan Limited stock at ₹252.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 29.16 and P/B ratio of 0.67. Today's performance shows a loss of 6.93%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Shivalik Rasayan Limited and when is the next dividend?
Shivalik Rasayan Limited offers a dividend yield of 0.22%, which means for every ₹100 invested at the current price of ₹252.50, you can expect to receive approximately ₹0.22 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Shivalik Rasayan Limited?
Shivalik Rasayan Limited's key financial metrics include: P/E Ratio: 29.16, P/B Ratio: 0.67, ROE: 3%, ROCE: 5.51%, Dividend Yield: 0.22%, EPS: ₹8.88, Book Value: ₹266.79, and Debt-to-Equity: 0.19. The company's market cap stands at ₹442.82 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Shivalik Rasayan Limited stock performing today in the market?
Shivalik Rasayan Limited stock opened at ₹275.70 and is currently trading at ₹252.50, showing a decline of ₹18.80 (6.93%). The intraday high is ₹275.70 and low is ₹250.10. The trading volume stands at 1,11,906 shares, indicating moderate market participation today.
08What is the P/E ratio of Shivalik Rasayan Limited and what does it indicate?
Shivalik Rasayan Limited has a Price-to-Earnings (P/E) ratio of 29.16, which means investors are willing to pay 29.16 for every ₹1 of earnings. With an EPS of ₹8.88, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Shivalik Rasayan Limited (SHIVALIK) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.